{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T05:47:16Z","timestamp":1742968036952,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":16,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071635407"},{"type":"electronic","value":"9781071635414"}],"license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3541-4_39","type":"book-chapter","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:27:05Z","timestamp":1701390425000},"page":"423-433","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Measurement of ThioTEPA and Its Metabolite TEPA in Plasma and Cerebrospinal Fluid by Turbulent Flow Chromatography-Tandem Mass Spectrometry"],"prefix":"10.1007","author":[{"given":"Ryan C.","family":"Schofield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Scordo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunjan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean C.","family":"Carlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"issue":"2","key":"39_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0305-7372(95)90023-3","volume":"21","author":"E Van der Wall","year":"1995","unstructured":"Van der Wall E, Beijnen JH, Rodenhuis S (1995) High-dose chemotherapy regimens for solid tumors. Cancer Treat Rev 21(2):105\u2013132","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"39_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/sj.bmt.1703105","volume":"28","author":"JG Schrama","year":"2001","unstructured":"Schrama JG, Baars JW, Holtkamp MJ, Schornagel JH, Beijnen JH, Rodenhuis S (2001) Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer. Bone Marrow Transplant 28(2):173\u2013180","journal-title":"Bone Marrow Transplant"},{"key":"39_CR3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1200\/JCO.1996.14.5.1473","volume":"14","author":"S Rodenhuis","year":"1996","unstructured":"Rodenhuis S, Westermann A, Holtkamp MJ, Nooijen WJ, Baars JW, Wall EVD, Slaper-Cortenbach IC (1996) Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer. J Clin Oncol 14:1473\u20131483","journal-title":"J Clin Oncol"},{"issue":"10","key":"39_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/oxfordjournals.annonc.a058111","volume":"3","author":"S Rodenhuis","year":"1992","unstructured":"Rodenhuis S, Baars JW, Schoraagel JH, Vlasveld LT, Mandjes I, Pinedo HM, Richel DJ (1992) Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantion incorporating carboplatin, cyclophosphamide and thiotepa. Ann Oncol 3(10):855\u2013860","journal-title":"Ann Oncol"},{"issue":"3","key":"39_CR5","first-page":"736","volume":"49","author":"RL Heideman","year":"1989","unstructured":"Heideman RL, Cole DE, Balis F, Sato J, Reaman GH, Packer RJ, Singher LJ, Ettinger LJ, Gillespie A, Sam J, Poplack DG (1989) Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa. Cancer Res 49(3):736\u2013741","journal-title":"Cancer Res"},{"issue":"3","key":"39_CR6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jms.570","volume":"39","author":"ME de Jonge","year":"2004","unstructured":"de Jonge ME, van Dam SM, Hillebrand MJ, Rosing H, Huitema AD, Rodenhuis S, Beijnen JH (2004) Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N\u2032,N\u2033-triethylenethiophosphoramide (thiotepa) and N,N\u2032,N\u2033-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J Mass Spectrom 39(3):262\u2013271","journal-title":"J Mass Spectrom"},{"issue":"7","key":"39_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.bmt.1702239","volume":"25","author":"T Demirer","year":"2000","unstructured":"Demirer T, Mandel NM, Arat M, G\u00fcnel N, \u00c7elebi H, \u00dcst\u00fcn C, Akan H, Demirer S, Ayd\u0131ntu\u011f S, Uysal A, Ko\u00e7 H (2000) A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies. Bone Marrow Transplant 25(7):697\u2013703","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"39_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s002770100344","volume":"80","author":"E Alessandrino","year":"2001","unstructured":"Alessandrino E, Bernasconi P, Colombo A, Caldera D, Bonfichi M, Pagnucco G, Malcovati L, Varettoni M, Lazzarino M, Bernasconi C (2001) Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. Ann Hematol 80(9):521\u2013524","journal-title":"Ann Hematol"},{"issue":"3","key":"39_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3109\/10428194.2013.806659","volume":"55","author":"T Bains","year":"2014","unstructured":"Bains T, Chen AI, Lemieux A, Hayes-Lattin BM, Leis JF, Dibb W, Maziarz RT (2014) Improved outcome with busulfan, melphalan and thiotepa conditioning in autologous hematopoietic stem cell transplant for relapsed\/refractory Hodgkin lymphoma. Leuk Lymphoma 55(3):583\u2013587","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"39_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/10428194.2015.1026901","volume":"57","author":"DH Oh","year":"2016","unstructured":"Oh DH, Chua N, Street L, Stewart DA (2016) Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan\/thiotepa-based conditioning and autologous stem cell transplant. Leuk Lymphoma 57(1):28\u201333","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"39_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3109\/10428194.2014.916800","volume":"56","author":"MR Welch","year":"2015","unstructured":"Welch MR, Sauter CS, Matasar MJ, Faivre G, Weaver SA, Moskowitz CH, Omuro AM (2015) Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide. Leuk Lymphoma 56(2):361\u2013367","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"39_CR12","first-page":"859","volume":"70","author":"BE Cohen","year":"1986","unstructured":"Cohen BE, Egorin MJ, Kohlhepp EA, Aisner J, Gutierrez PL (1986) Human plasma pharmacokinetics and urinary excretion of thiotepa and its metabolites. Cancer Treat Rep 70(7):859","journal-title":"Cancer Treat Rep"},{"issue":"4","key":"39_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1053\/ctrv.2000.0170","volume":"26","author":"MJ Van Maanen","year":"2000","unstructured":"Van Maanen MJ, Smeets CJM, Beijnen JH (2000) Chemistry, pharmacology and pharmacokinetics of N,N\u2032,N\u2032\u2032-triethylenethiophosphoramide (ThioTEPA). Cancer Treat Rev 26(4):257\u2013268","journal-title":"Cancer Treat Rev"},{"issue":"12_Part_1","key":"39_CR14","first-page":"6101","volume":"46","author":"JM Strong","year":"1986","unstructured":"Strong JM, Collins JM, Lester C, Poplack DG (1986) Pharmacokinetics of intraventricular and intravenous N,N\u2032,N\u2033-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. Cancer Res 46(12_Part_1):6101\u20136104","journal-title":"Cancer Res"},{"issue":"7","key":"39_CR15","first-page":"1549","volume":"66","author":"DL Trump","year":"1982","unstructured":"Trump DL, Grossman SA, Thompson G, Murray K, Wharam M (1982) Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexate. Cancer Treat Rep 66(7):1549\u20131551","journal-title":"Cancer Treat Rep"},{"issue":"12","key":"39_CR16","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3109\/10428194.2014.889825","volume":"55","author":"MB Kokolo","year":"2014","unstructured":"Kokolo MB, Fergusson D, O\u2019Neill J, Tay J, Tinmouth AT, Stewart D, Bredeson C (2014) Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma. Leuk Lymphoma 55(12):2712\u20132720","journal-title":"Leuk Lymphoma"}],"container-title":["Methods in Molecular Biology","Clinical Applications of Mass Spectrometry in Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3541-4_39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:33:48Z","timestamp":1701390828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3541-4_39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"ISBN":["9781071635407","9781071635414"],"references-count":16,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3541-4_39","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"1 December 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}